SCHEMBL26931925

SCHEMBL26931925

COCCOc1cc(Br)cnc1I

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.36
SLC6A4 P31645 1/20 0.36
KDM1A O60341 5/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
EGFR P00533 2/20 0.34
ERBB2 P04626 1/20 0.34
FBP1 P09467 1/20 0.33
ALDH1A1 P00352 2/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PI4KA P42356 1/20 0.32
PIK3CG P48736 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
RECQL P46063 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
S1PR4 O95977 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30683028 1.00 PLAU (0.36) PLAUSLC6A4KDM1AL3MBTL1POLB
SCHEMBL1621948 0.87 RECQL (0.32) RECQL
SCHEMBL23292092 0.84 EGFR (0.33) EGFRERBB2ALDH1A1RECQLKMT2A
SCHEMBL25873582 0.81 PLAU (0.37) PLAUSLC6A4KDM1AL3MBTL1POLB
SCHEMBL29021806 0.80 GRM5 (0.44) L3MBTL1POLBALDH1A1MEN1KMT2A
SCHEMBL4296773 0.80 DYRK1B (0.36) POLBALDH1A1MEN1KMT2A
SCHEMBL17593337 0.79 PLAU (0.42) PLAUKDM1AL3MBTL1POLBEGFR
SCHEMBL188937 0.79 PIK3CA (0.37) PLAUSLC6A4KDM1AL3MBTL1POLB
SCHEMBL29812510 0.79 PLAU (0.42) PLAUKDM1AL3MBTL1POLBEGFR
SCHEMBL3146860 0.79 KMT2A (0.46) PLAUKDM1APOLBPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239645-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-12-14 WO disclosed
WO-2023239645-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-12-14 WO disclosed